We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A New York union has filed a class-action lawsuit against AbbVie and seven other drugmakers, accusing them of throwing up a “patent thicket” to keep cheaper rivals to AbbVie’s blockbuster drug Humira off the market.